GWM
PJP icon

Gilpin Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Gilpin Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$803K Sell
6,514
-204
-3% -$25.3K 0.54% 55
2026
Q2 		$796K Sell
6,718
-206
-3% -$22.3K 0.55% 55
2026
Q1 		$718K Sell
6,924
-106
-2% -$11.2K 0.57% 52
2025
Q4 		$735K Buy
+7,030
New +$707K 0.58% 49

Other funds holding PJP

SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return

Gilpin Wealth Management's PJP Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 3% in Q3 2026, selling an estimated $25.3K and leaving 6,514 shares worth $803K. The position accounts for 0.54% of the portfolio, ranked #55.

Gilpin Wealth Management first reported a position in PJP in Q4 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Gilpin Wealth Management held 6,514 shares of Invesco Pharmaceuticals ETF worth $803K as of Q3 2026.
  • Gilpin Wealth Management sold 204 Invesco Pharmaceuticals ETF shares in Q3 2026, an estimated $25.3K.
  • Invesco Pharmaceuticals ETF made up 0.54% of Gilpin Wealth Management's portfolio in Q3 2026, its #55 holding.
  • Gilpin Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2025 and has held it in 4 quarters since.
  • 6 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.